BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34364705)

  • 1. YAP1 protein expression has variant prognostic significance in small cell lung cancer (SCLC) stratified by histological subtypes.
    Wang X; Guo Y; Liu L; Wei J; Zhang J; Xie T; Dong J; Li J; Xing P; Yang L
    Lung Cancer; 2021 Oct; 160():166-174. PubMed ID: 34364705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance.
    Hwang S; Hong TH; Kim HK; Choi YS; Zo JI; Shim YM; Han J; Chan Ahn Y; Pyo H; Noh JM; Lee HY; Kim HJ; Park S; Ahn MJ; Park K; Lee SH; Choi YL; Kim J
    Mod Pathol; 2023 Jul; 36(7):100184. PubMed ID: 37054974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection.
    Guo Y; Yang L; Liu L; Wei J; Teng F; Zhang J; Zhu Y; Xing P; Li J
    Thorac Cancer; 2020 Oct; 11(10):2782-2792. PubMed ID: 32779385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma.
    Zhu Y; Li S; Wang H; Chi K; Ren W; Huang X; Zhuo M; Lin D
    Hum Pathol; 2023 Nov; 141():118-129. PubMed ID: 37586462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
    Megyesfalvi Z; Barany N; Lantos A; Valko Z; Pipek O; Lang C; Schwendenwein A; Oberndorfer F; Paku S; Ferencz B; Dezso K; Fillinger J; Lohinai Z; Moldvay J; Galffy G; Szeitz B; Rezeli M; Rivard C; Hirsch FR; Brcic L; Popper H; Kern I; Kovacevic M; Skarda J; Mittak M; Marko-Varga G; Bogos K; Renyi-Vamos F; Hoda MA; Klikovits T; Hoetzenecker K; Schelch K; Laszlo V; Dome B
    J Pathol; 2022 Aug; 257(5):674-686. PubMed ID: 35489038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of histological subtype and treatment modalities on T1-2 N0-1 small cell lung cancer: A population-based study.
    Moon SW; Seo JH; Jeon HW; Moon MH
    Thorac Cancer; 2019 May; 10(5):1229-1240. PubMed ID: 30993901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer.
    Li Y; Wang Y; Zhou W; Chen Y; Lou Y; Qian F; Lu J; Jiang H; Xiang B; Zhang Y; Han B; Zhang W
    Thorac Cancer; 2022 Oct; 13(19):2711-2722. PubMed ID: 36054506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer.
    Lang C; Megyesfalvi Z; Lantos A; Oberndorfer F; Hoda MA; Solta A; Ferencz B; Fillinger J; Solyom-Tisza A; Querner AS; Egger F; Boettiger K; Klikovits T; Timelthaler G; Renyi-Vamos F; Aigner C; Hoetzenecker K; Laszlo V; Schelch K; Dome B
    World J Surg Oncol; 2024 Feb; 22(1):57. PubMed ID: 38369463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer.
    Fujii K; Miyata Y; Takahashi I; Koizumi H; Saji H; Hoshikawa M; Takagi M; Nishimura T; Nakamura H
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800015. PubMed ID: 29888431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary tumor standardized uptake value (SUVmax) measured on
    Hui Z; Wei F; Ren H; Xu W; Ren X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer.
    Wei J; Liu L; Guo Y; Zhang J; Wang X; Dong J; Xing P; Ying J; Yang L; Li J
    Thorac Cancer; 2021 Jan; 12(1):40-47. PubMed ID: 33191657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer.
    Dora D; Rivard C; Yu H; Pickard SL; Laszlo V; Harko T; Megyesfalvi Z; Gerdan C; Dinya E; Hoetzenecker K; Hirsch FR; Lohinai Z; Dome B
    Cancer Immunol Immunother; 2023 Mar; 72(3):561-578. PubMed ID: 35978199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
    Wang X; Jiang R; Li K
    Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resected Pure Small Cell Lung Carcinomas and Combined Small Cell Lung Carcinomas: Histopathology Features, Imaging Features, and Prognoses.
    Woo JH; Kim MY; Lee KS; Jeong DY; Chung MJ; Han J; Shim YM
    AJR Am J Roentgenol; 2019 Apr; 212(4):773-781. PubMed ID: 30673331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer.
    Keogh A; Finn S; Radonic T
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of focal adhesion kinase in small-cell lung carcinoma.
    Ocak S; Chen H; Callison C; Gonzalez AL; Massion PP
    Cancer; 2012 Mar; 118(5):1293-301. PubMed ID: 21800286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Zhang Z; Zhang C; Luo Y; Wu P; Zhang G; Zeng Q; Wang L; Yang Z; Xue L; Zheng B; Zeng H; Tan F; Xue Q; Gao S; Sun N; He J
    BMC Med; 2021 Nov; 19(1):284. PubMed ID: 34802443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
    Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A
    J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity.
    Qi J; Zhang J; Liu N; Zhao L; Xu B
    Front Oncol; 2022; 12():779276. PubMed ID: 35311069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC).
    Ding XL; Su YG; Yu L; Bai ZL; Bai XH; Chen XZ; Yang X; Zhao R; He JX; Wang YY
    World J Surg Oncol; 2022 Feb; 20(1):54. PubMed ID: 35220975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.